Morniflumate

Morniflumate
Clinical data
AHFS/Drugs.com	International Drug Names
ATC code	M01AX22 (WHO) ;
Identifiers
	IUPAC name 2-morpholin-4-ylethyl 2-{[3-(trifluoromethyl)phenyl]amino}nicotinate;
CAS Number	65847-85-0 Y;
PubChem CID	72106;
ChemSpider	65089 Y;
UNII	R133MWH7X1;
KEGG	D05078 Y;
CompTox Dashboard (EPA)	DTXSID6057798 ;
ECHA InfoCard	100.207.566
Chemical and physical data
Formula	C19H20F3N3O3
Molar mass	395.382 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES FC(F)(F)c1cc(ccc1)Nc2ncccc2C(=O)OCCN3CCOCC3;
	InChI InChI=1S/C19H20F3N3O3/c20-19(21,22)14-3-1-4-15(13-14)24-17-16(5-2-6-23-17)18(26)28-12-9-25-7-10-27-11-8-25/h1-6,13H,7-12H2,(H,23,24) Y; Key:LDXSPUSKBDTEKA-UHFFFAOYSA-N Y;
	(verify)

Chemical compound

Pharmaceutical compound

Morniflumate is a nonsteroidal anti-inflammatory drug (NSAID).^[1]^[2]^[3]

References

^ Melica A, Donateo L, Gerardi R, Parenti M (1991). "[A new anti-inflammatory-analgesic-antipyretic, morniflumate, in the treatment of chronic recurring bronchitis]". Rivista Europea per le Scienze Mediche e Farmacologiche = European Review for Medical and Pharmacological Sciences = Revue Européenne Pour les Sciences Médicales et Pharmacologiques. 13 (1–2): 51–60. PMID 1796197.
^ Civelli M, Vigano T, Acerbi D, Caruso P, Giossi M, Bongrani S, Folco GC (July 1991). "Modulation of arachidonic acid metabolism by orally administered morniflumate in man". Agents and Actions. 33 (3–4): 233–9. doi:10.1007/bf01986568. PMID 1659152.
^ Schiantarelli P, Cadel S, Acerbi D (February 1984). "A gastroprotective anti-inflammatory agent: the beta-morpholinoethyl ester of niflumic acid (morniflumate)". Agents and Actions. 14 (2): 247–56. doi:10.1007/BF01966649. PMID 6608862.

This drug article relating to the musculoskeletal system is a stub. You can help Wikipedia by expanding it.